[(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)][(EgKI-1,giving rise to,hydatid cyst,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,0.9784992011044717), (EgKI-1,is highly expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,is expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,member of,Kunitz type protease inhibitor family,1.0), (canine tapeworm Echinococcus granulosus,of oncosphere is,stage,1.0), (EgKI-1,is expressed by,oncosphere,1.0), (EgKI-1,giving rise to,hydatid cyst localized,1.0), (EgKI-1,is expressed by,oncosphere of tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving,rise,1.0), (EgKI-1,is highly expressed by,oncosphere of canine tapeworm Echinococcus granulosus,1.0), (EgKI-1,giving rise to,cyst,1.0), (EgKI-1,is highly expressed by,oncosphere,1.0), (EgKI-1,giving rise to,cyst localized to liver,1.0), (EgKI-1,giving rise to,hydatid cyst localized to liver,1.0), (EgKI-1,is,expressed,1.0), (EgKI-1,is,highly expressed,1.0), (EgKI-1,giving rise to,cyst localized,1.0)]

[(recombinant EgKI-1,inhibits,growth,1.0), (recombinant EgKI-1,inhibits,migration,1.0), (recombinant EgKI-1,affecting,normal cell growth,1.0), (recombinant EgKI-1,affecting,cell growth,1.0), (EgKI-1,inhibits,growth,1.0), (EgKI-1,inhibits,migration,1.0), (EgKI-1,affecting,cell growth,1.0), (EgKI-1,affecting,normal cell growth,1.0)][(recombinant EgKI-1,inhibits,growth,1.0), (recombinant EgKI-1,inhibits,migration,1.0), (recombinant EgKI-1,affecting,normal cell growth,1.0), (recombinant EgKI-1,affecting,cell growth,1.0), (EgKI-1,inhibits,growth,1.0), (EgKI-1,inhibits,migration,1.0), (EgKI-1,affecting,cell growth,1.0), (EgKI-1,affecting,normal cell growth,1.0)][(recombinant EgKI-1,inhibits,growth,1.0), (recombinant EgKI-1,inhibits,migration,1.0), (recombinant EgKI-1,affecting,normal cell growth,1.0), (recombinant EgKI-1,affecting,cell growth,1.0), (EgKI-1,inhibits,growth,1.0), (EgKI-1,inhibits,migration,1.0), (EgKI-1,affecting,cell growth,1.0), (EgKI-1,affecting,normal cell growth,1.0)][(recombinant EgKI-1,inhibits,growth,1.0), (recombinant EgKI-1,inhibits,migration,1.0), (recombinant EgKI-1,affecting,normal cell growth,1.0), (recombinant EgKI-1,affecting,cell growth,1.0), (EgKI-1,inhibits,growth,1.0), (EgKI-1,inhibits,migration,1.0), (EgKI-1,affecting,cell growth,1.0), (EgKI-1,affecting,normal cell growth,1.0)][(recombinant EgKI-1,inhibits,growth,1.0), (recombinant EgKI-1,inhibits,migration,1.0), (recombinant EgKI-1,affecting,normal cell growth,1.0), (recombinant EgKI-1,affecting,cell growth,1.0), (EgKI-1,inhibits,growth,1.0), (EgKI-1,inhibits,migration,1.0), (EgKI-1,affecting,cell growth,1.0), (EgKI-1,affecting,normal cell growth,1.0)][(recombinant EgKI-1,inhibits,growth,1.0), (recombinant EgKI-1,inhibits,migration,1.0), (recombinant EgKI-1,affecting,normal cell growth,1.0), (recombinant EgKI-1,affecting,cell growth,1.0), (EgKI-1,inhibits,growth,1.0), (EgKI-1,inhibits,migration,1.0), (EgKI-1,affecting,cell growth,1.0), (EgKI-1,affecting,normal cell growth,1.0)][(recombinant EgKI-1,inhibits,growth,1.0), (recombinant EgKI-1,inhibits,migration,1.0), (recombinant EgKI-1,affecting,normal cell growth,1.0), (recombinant EgKI-1,affecting,cell growth,1.0), (EgKI-1,inhibits,growth,1.0), (EgKI-1,inhibits,migration,1.0), (EgKI-1,affecting,cell growth,1.0), (EgKI-1,affecting,normal cell growth,1.0)][(recombinant EgKI-1,inhibits,growth,1.0), (recombinant EgKI-1,inhibits,migration,1.0), (recombinant EgKI-1,affecting,normal cell growth,1.0), (recombinant EgKI-1,affecting,cell growth,1.0), (EgKI-1,inhibits,growth,1.0), (EgKI-1,inhibits,migration,1.0), (EgKI-1,affecting,cell growth,1.0), (EgKI-1,affecting,normal cell growth,1.0)]
[(EgKI-1 treatment,disrupting,cell cycle,1.0), (EgKI-1 treatment,arrested,cancer cell growth,1.0), (cell cycle,apoptosis of,cancer cells,1.0), (EgKI-1 treatment,Furthermore arrested,cancer cell growth,1.0), (cell cycle,induced apoptosis of,cancer cells,1.0)][(EgKI-1 treatment,disrupting,cell cycle,1.0), (EgKI-1 treatment,arrested,cancer cell growth,1.0), (cell cycle,apoptosis of,cancer cells,1.0), (EgKI-1 treatment,Furthermore arrested,cancer cell growth,1.0), (cell cycle,induced apoptosis of,cancer cells,1.0)][(EgKI-1 treatment,disrupting,cell cycle,1.0), (EgKI-1 treatment,arrested,cancer cell growth,1.0), (cell cycle,apoptosis of,cancer cells,1.0), (EgKI-1 treatment,Furthermore arrested,cancer cell growth,1.0), (cell cycle,induced apoptosis of,cancer cells,1.0)][(EgKI-1 treatment,disrupting,cell cycle,1.0), (EgKI-1 treatment,arrested,cancer cell growth,1.0), (cell cycle,apoptosis of,cancer cells,1.0), (EgKI-1 treatment,Furthermore arrested,cancer cell growth,1.0), (cell cycle,induced apoptosis of,cancer cells,1.0)][(EgKI-1 treatment,disrupting,cell cycle,1.0), (EgKI-1 treatment,arrested,cancer cell growth,1.0), (cell cycle,apoptosis of,cancer cells,1.0), (EgKI-1 treatment,Furthermore arrested,cancer cell growth,1.0), (cell cycle,induced apoptosis of,cancer cells,1.0)]
[(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)][(in model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (in model,is in,BALB/c nude mice,1.0), (model,showed,tumor growth reduction in mice,1.0), (in model,showed,tumor growth reduction,1.0), (significant tumor growth reduction,is in,EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in mice,1.0), (in model,showed,significant tumor growth reduction in mice,1.0), (model,showed,significant tumor growth reduction,1.0), (model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,significant tumor growth reduction in EgKI-1-treated mice,1.0), (in model,showed,tumor growth reduction in mice,1.0), (model,showed,tumor growth reduction in EgKI-1-treated mice,1.0), (model,showed,tumor growth reduction,1.0)]
[(EgKI-1,shows,promise for future development,1.0), (EgKI-1,promise for,future development,0.6295364205189024), (EgKI-1,shows promise as,anti-cancer therapeutic,1.0), (EgKI-1,shows,promise,1.0), (EgKI-1,shows promise as,therapeutic,1.0)][(EgKI-1,shows,promise for future development,1.0), (EgKI-1,promise for,future development,0.6295364205189024), (EgKI-1,shows promise as,anti-cancer therapeutic,1.0), (EgKI-1,shows,promise,1.0), (EgKI-1,shows promise as,therapeutic,1.0)][(EgKI-1,shows,promise for future development,1.0), (EgKI-1,promise for,future development,0.6295364205189024), (EgKI-1,shows promise as,anti-cancer therapeutic,1.0), (EgKI-1,shows,promise,1.0), (EgKI-1,shows promise as,therapeutic,1.0)][(EgKI-1,shows,promise for future development,1.0), (EgKI-1,promise for,future development,0.6295364205189024), (EgKI-1,shows promise as,anti-cancer therapeutic,1.0), (EgKI-1,shows,promise,1.0), (EgKI-1,shows promise as,therapeutic,1.0)][(EgKI-1,shows,promise for future development,1.0), (EgKI-1,promise for,future development,0.6295364205189024), (EgKI-1,shows promise as,anti-cancer therapeutic,1.0), (EgKI-1,shows,promise,1.0), (EgKI-1,shows promise as,therapeutic,1.0)]
------Triplets found are 634-------